Agilent beats by $0.04, beats on revs; guides AprQ EPS in-line, revs in-line; reaffirms FY17 EPS guidance, guides FY17 revs in-line :
- Reports Q1 (Jan) earnings of $0.53 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus of $0.49 and above prior guidance of $0.48-0.50; revenues rose 3.8% year/year to $1.07 bln vs the $1.05 bln Capital IQ Consensus and vs prior guidance of $1.04-1.06 bln.
- Co issues in-line guidance for Q2 (Apr), sees EPS of $0.47-0.49, excluding non-recurring items, vs. $0.49 Capital IQ Consensus Estimate; sees Q2 revs of $1.04-1.06 bln vs. $1.05 bln Capital IQ Consensus Estimate.
- Co issues guidance for FY17, reaffirms EPS of $2.10-2.16, excluding non-recurring items, vs. $2.14 Capital IQ Consensus Estimate; sees FY17 revs of $4.33-4.35 bln vs. $4.34 bln Capital IQ Consensus Estimate.
- "Our strong revenue results were driven by a return to growth in our Chemical & Energy business and higher-than-expected China growth. Overall, we are confident in the company's prospects, and we are raising our full-year core revenue growth expectations."
No comments:
Post a Comment